Tempus AI (NASDAQ:TEM) Coverage Initiated by Analysts at William Blair

Stock analysts at William Blair started coverage on shares of Tempus AI (NASDAQ:TEM) in a report released on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating on the stock.

A number of other research firms also recently commented on TEM. Stifel Nicolaus started coverage on shares of Tempus AI in a report on Tuesday. They issued a “buy” rating and a $45.00 target price on the stock. Morgan Stanley started coverage on Tempus AI in a research report on Tuesday. They set an “overweight” rating and a $44.00 price objective for the company. Needham & Company LLC began coverage on Tempus AI in a report on Tuesday. They issued a “buy” rating and a $47.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on Tempus AI in a research report on Tuesday. They set an “overweight” rating and a $42.00 target price on the stock. Finally, Loop Capital started coverage on Tempus AI in a research report on Tuesday. They issued a “buy” rating and a $48.00 price target for the company. Nine investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Tempus AI currently has a consensus rating of “Buy” and a consensus target price of $45.63.

Tempus AI Price Performance

NASDAQ:TEM opened at $35.00 on Tuesday. Tempus AI has a 52-week low of $22.89 and a 52-week high of $43.88.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.